SEC Form 4 · accession 0001437749-16-040364
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas Tompkins
Director
Period of report
Oct 20, 2016
Accepted (ET)
Oct 26, 2016 · 5:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 20, 2016 | M | 2,201 | $13.80 | A | 52,914 | I | Held in Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F1,F3 | $13.80 | Oct 20, 2016 | M | 2,201 | D | Oct 20, 2016 | Oct 20, 2016 | Common Stock | 2,201 | 0 | I |
Explanation of responses
- F1The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
- F2The restricted stock units were granted on May 25, 2016.
- F3The restricted stock units vested on October 20, 2016.